Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Double heterozygous mutation in RAD50 and ATM genes in a Peruvian family with five cancer types: a case report.

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) - 7 Mar 2022

Sánchez Castro Enrique Eduardo, Ziegler-Rodriguez Gonzalo, Castro Mujica María Del Carmen

Abstract excerpt

INTRODUCTION: Cancer is the second leading cause of death worldwide, with 70% of cancer deaths occurring in low- or middle- income countries. To mitigate the mortality of this disease, it is recommended the evaluation of multiple high-penetrance genes. METHODS: We used a multi-gene panel testing to identify germline variants in a unique case of a breast cancer patient with a family history of five different...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acid Anhydride Hydrolases
Share to Ataxia Telangiectasia Mutated Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to DNA-Binding Proteins

Share to Genetic Counseling

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 35312250
DOI: 10.31053/1853.0605.v79.n1.32795
PMCID: PMC9004297

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Double heterozygous mutation in RAD50 and ATM genes in a Peruvian family with five cancer types: a case report.PMID 35312250Read ↗

Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.Semantic proximity Read ↗

What About the Others? Clinical Management of Gynecologic Cancer Risk in Patients With Moderate-Risk Hereditary Cancer Genes ( ATM , BRIP1 , RAD51C , RAD51D , and PALB2 ).Semantic proximity Read ↗

Multi gene panel testing for hereditary breast cancer - is it ready to be used?Semantic proximity Read ↗

Homologous Recombination Deficiency: Cancer Predispositions and Treatment Implications.Semantic proximity Read ↗

Coinheritance of pathogenic variants in ATM and BRCA2 in families with multiple cancers: a case seriesSemantic proximity Read ↗

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.Semantic proximity Read ↗

Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.Semantic proximity Read ↗

The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.Semantic proximity Read ↗

Cancer risks associated with heterozygous ATM loss of function and missense pathogenic variants based on multigene panel analysis.Semantic proximity Read ↗

A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genesSemantic proximity Read ↗

Concurrent pathogenic variations in patients with hereditary cancer syndromes.Semantic proximity Read ↗

Multigene germline testing usefulness instead of BRCA1/2 single screening in triple negative breast cancer cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.